148 related articles for article (PubMed ID: 31773842)
41. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Anayannis NV; Schlecht NF; Belbin TJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
[TBL] [Abstract][Full Text] [Related]
42. Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status.
Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Wilson E; Bumpous J; Potts K; Perez C; Bert R; Redman R; Dunlap N
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):349-353. PubMed ID: 27598805
[TBL] [Abstract][Full Text] [Related]
43. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
[TBL] [Abstract][Full Text] [Related]
44. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
45. PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
Park HC; Kim H; Kim JY; Lee HY; Lee J; Cha W; Ahn SH; Jeong WJ
BMC Cancer; 2023 Dec; 23(1):1242. PubMed ID: 38104103
[TBL] [Abstract][Full Text] [Related]
46. Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma.
Marks JA; Switchenko JM; Steuer CE; Ryan M; Patel MR; McDonald MW; Higgins K; Beitler JJ; Shin DM; Gillespie TW; Saba NF
JCO Oncol Pract; 2021 Mar; 17(3):e313-e322. PubMed ID: 33434083
[TBL] [Abstract][Full Text] [Related]
47. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
48. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
[TBL] [Abstract][Full Text] [Related]
49. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients.
Haave H; Gulati S; Brekke J; Lybak S; Vintermyr OK; Aarstad HJ
Acta Otolaryngol; 2018 Nov; 138(11):1035-1042. PubMed ID: 30734620
[TBL] [Abstract][Full Text] [Related]
50. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
[TBL] [Abstract][Full Text] [Related]
51. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
[TBL] [Abstract][Full Text] [Related]
52. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
[TBL] [Abstract][Full Text] [Related]
53. [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications].
Reuschenbach M; Wagner S; Würdemann N; Sharma SJ; Prigge ES; Sauer M; Wittig A; Wittekindt C; von Knebel Doeberitz M; Klussmann JP
HNO; 2016 Jul; 64(7):450-9. PubMed ID: 26864190
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
55. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
56. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
[TBL] [Abstract][Full Text] [Related]
57. African Americans With p16+ and p16- Oropharyngeal Squamous Cell Carcinomas Have Distinctly Poor Treatment Outcomes Independent of Medical Care Access.
O'Neill WQ; Wasman J; Thuener J; Chatfield-Reed K; Lukesic L; Kyasram R; Shanahan J; Szelesety B; Vu B; Lavertu P; Rezaee R; Li S; Fowler N; Teknos TN; Pan Q
JCO Oncol Pract; 2021 May; 17(5):e695-e702. PubMed ID: 33974822
[TBL] [Abstract][Full Text] [Related]
58. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
[TBL] [Abstract][Full Text] [Related]
59. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
[TBL] [Abstract][Full Text] [Related]
60. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
